Skip to content

RECUREX: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

RECUREX

BE 0823.449.331
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 31-12-2023 against 31-12-2024filed annual accounts (NBB)
Net result for the year
-€3,293
31-12-2023 · -€3,701+€408
Equity
-€79,371
31-12-2023 · -€76,079-€3,293
Cash
€793
31-12-2023 · €76+€717
Balance sheet total
€3,342
31-12-2023 · €2,694+€648

Largest movements

31-12-2023 to 31-12-2024
Assets
  • Cash +€717

    up €717 (+947.2%), from €76 to €793

    mainly Other debts (+€3,940) and Depreciation (+€213)

  • Tangible fixed assets -€213

    down €213 (-50.0%), from €425 to €213

  • Receivables within one year +€143

    up €143 (+22.9%), from €624 to €768

Equity and liabilities
  • Other debts +€3,940

    up €3,940 (+5.0%), from €78,772 to €82,713

  • Profit (loss) carried forward -€3,293

    down €3,293 (-4.0%), from -€82,279 to -€85,571

Income statement
  • Gross operating margin +€1,330

    up €1,330 (+40.4%), from -€3,289 to -€1,959

  • Other operating charges +€933

    up €933 (+1006.4%), from €93 to €1,026

From the 31-12-2023 result to the 31-12-2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 31-12-2023 -€3,701
Gross operating margin +€1,330
Other operating charges -€933
Financial charges +€11
Result 31-12-2024 -€3,293

Cash bridge derived

cash 31-12-2023 to 31-12-2024

Derived from the 31-12-2023 and 31-12-2024 balance sheets and the 31-12-2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€717
Investment €0
Financing €0
Cash 31-12-2023 €76
Net result for the year -€3,293
Depreciation +€213
Receivables within one year -€143
Other debts +€3,940
Cash 31-12-2024 €793
Every line side by side 29 lines
Line Code 31-12-2023 31-12-2024 Change %
Total assets 20/58 €2,694 €3,342 +€648 +24.0%
Fixed assets 21/28 €894 €681 -€213 -23.8%
Tangible fixed assets 22/27 €425 €213 -€213 -50.0%
Other tangible fixed assets 26 €425 €213 -€213 -50.0%
Financial fixed assets 28 €469 €469 = 0.0%
Current assets 29/58 €1,800 €2,660 +€860 +47.8%
Stocks and contracts in progress 3 €1,100 €1,100 = 0.0%
Stocks 30/36 €1,100 €1,100 = 0.0%
Amounts receivable within one year 40/41 €624 €768 +€143 +22.9%
Other amounts receivable 41 €624 €768 +€143 +22.9%
Cash at bank and in hand 54/58 €76 €793 +€717 +947.2%
Total equity and liabilities 10/49 €2,694 €3,342 +€648 +24.0%
Equity 10/15 -€76,079 -€79,371 -€3,293 -4.3%
Contributions 10/11 €6,200 €6,200 = 0.0%
Capital 10 €6,200 - -€6,200
Issued capital 100 €6,200 - -€6,200
Profit (loss) carried forward 14 -€82,279 -€85,571 -€3,293 -4.0%
Amounts payable 17/49 €78,772 €82,713 +€3,940 +5.0%
Amounts payable within one year 42/48 €78,772 €82,713 +€3,940 +5.0%
Other amounts payable 47/48 €78,772 €82,713 +€3,940 +5.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €213 €213 = 0.0%
Other operating charges 640/8 €93 €1,026 +€933 +1006.4%
Gross operating margin 9900 -€3,289 -€1,959 +€1,330 +40.4%
Operating profit (loss) 9901 -€3,594 -€3,197 +€397 +11.0%
Financial charges 65/66B €106 €95 -€11 -10.4%
Recurring financial charges 65 €106 €95 -€11 -10.4%
Profit (loss) for the period before taxes 9903 -€3,701 -€3,293 +€408 +11.0%
Profit (loss) for the period 9904 -€3,701 -€3,293 +€408 +11.0%
Profit (loss) for the period to be appropriated 9905 -€3,701 -€3,293 +€408 +11.0%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.